The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
Newly-published NCCN Guidelines for Patients: Quitting Smoking explains what the evidence and expert consensus is on how to best use the tools that exist to help anyone quit for good.
NCCN expands guidelines to create two major resources for helping cancer care providers and other stakeholders stay current on cutting edge research on genetic/familial high-risk assessment.
Leaders from the National Comprehensive Cancer Network (NCCN) travel to Vietnam to collaborate with Vietnam National Cancer Hospital on improving cancer care standards throughout the country.
International oncology experts gather in Accra, Ghana for a series of meetings to update cancer treatment recommendations in the NCCN Harmonized Guidelines™ for Sub-Saharan Africa.
National Comprehensive Cancer Network (NCCN) presents preliminary data from a study demonstrating the usability of the Health Equity Report Card (HERC) tool during the American Public Health Association (APHA) Annual Meeting and Expo.
New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).
NCCN announces a renewed collaboration with LACOG to publish new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer: Brazil Edition. Additional Brazilian adaptations of NCCN Guidelines for other cancer types are planned for the future.
The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.
Speakers at an NCCN Oncology Policy Summit discuss the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve cancer outcomes, and what to do about backlash.
New research just-published online by JNCCN—Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic GI cancers, it is possible to administer 5-FU solely through continuous infusion, minus the bolus component, without negatively affecting patient outcomes.
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncology guidelines in China.
The National Comprehensive Cancer Network (NCCN)’s research arm achieves major milestone, showcasing years of success in fostering innovation and knowledge discovery that improves the lives of patients with cancer.
NCCN shares new data on continued high prevalence for cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.
NCCN Guidelines for Patients earn Hermes Award for electronic media and Communicator Award for medical print content. NCCN Patient Webinars earn Digital Health Award and Viddy Award for outstanding achievement in video and digital production.
Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute found significant uptake and scalability in phone-based “PATH” intervention to improve psychological well-being in blood cancer patients, according to new study in JNCCN.
The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines for Poland.
The NCCN Guidelines for Patients: Small Bowel Adenocarcinoma are now available for free download at NCCN.org/patientguidelines, thanks to funding from the NCCN Foundation®.
Daniel M. Geynisman, MD, is being announced the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman, Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has a long history of working with NCCN in a variety of roles.
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—hosts an oncology policy summit focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right